News
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth ...
Merck stock fell in premarket trading Tuesday after the pharmaceutical giant posted second-quarter earnings and said it would ...
Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...
The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...
Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.
For $10 billion, Merck is acquiring a promising healthcare company which is in the early stages of its growth. Key to its potential is Ohtuvayre, a blockbuster drug that regulators approved last year ...
Dragged down by losses for shares of UnitedHealth and Merck, the Dow Jones Industrial Average is falling Thursday afternoon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback